200 related articles for article (PubMed ID: 23404201)
21. Guideline Promotion Increases Prescription of Bone Protection with Steroids in Hospitalised Patients.
Harty L; Clare J; Finnerty D; van der Kamp S; Kennedy F; Callanan I; McKenna MJ; FitzGerald O
Ir Med J; 2015; 108(7):216-7. PubMed ID: 26349354
[TBL] [Abstract][Full Text] [Related]
22. [Glucocorticoid-induced osteoporosis : treatment update].
Soen S
Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
[TBL] [Abstract][Full Text] [Related]
23. Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.
Jayasena A; Atapattu N; Lekamwasam S
Int J Rheum Dis; 2015 Mar; 18(3):287-93. PubMed ID: 25923606
[TBL] [Abstract][Full Text] [Related]
24. How to prevent glucocorticoid-induced osteoporosis.
Dore RK
Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-Induced Osteoporosis Program (GIOP): a novel, comprehensive, and highly successful care program with improved outcomes at 1 year.
Newman ED; Matzko CK; Olenginski TP; Perruquet JL; Harrington TM; Maloney-Saxon G; Culp T; Wood GC
Osteoporos Int; 2006; 17(9):1428-34. PubMed ID: 16865312
[TBL] [Abstract][Full Text] [Related]
26. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
Trials; 2015 May; 16():214. PubMed ID: 25962885
[TBL] [Abstract][Full Text] [Related]
27. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
Majumdar SR; Lix LM; Yogendran M; Morin SN; Metge CJ; Leslie WD
J Clin Endocrinol Metab; 2012 Apr; 97(4):1236-42. PubMed ID: 22298803
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
Bak M; Serdaroglu E; Guclu R
Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
[TBL] [Abstract][Full Text] [Related]
29. [Osteoporosis - Is There An Indication For Vitamin D Supplementation?].
Schlereth F; Badenhoop K
Dtsch Med Wochenschr; 2019 Aug; 144(16):1120-1124. PubMed ID: 31416103
[TBL] [Abstract][Full Text] [Related]
30. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
[TBL] [Abstract][Full Text] [Related]
31. [Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium].
Ringe JD; Cöster A; Meng T; Schacht E; Umbach R
Z Rheumatol; 2000 Jun; 59(3):176-82. PubMed ID: 10929446
[TBL] [Abstract][Full Text] [Related]
32. An interdisciplinary knowledge translation intervention in long-term care: study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
Kennedy CC; Ioannidis G; Giangregorio LM; Adachi JD; Thabane L; Morin SN; Crilly RG; Marr S; Josse RG; Lohfeld L; Pickard LE; King S; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
Implement Sci; 2012 May; 7():48. PubMed ID: 22624776
[TBL] [Abstract][Full Text] [Related]
33. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.
Yood RA; Harrold LR; Fish L; Cernieux J; Emani S; Conboy E; Gurwitz JH
Arch Intern Med; 2001 May; 161(10):1322-7. PubMed ID: 11371261
[TBL] [Abstract][Full Text] [Related]
34. Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital.
Suda M; Suyama Y; Ohde S; Tsuda T; Sawada H; Kishimoto M; Okada M
Int J Rheum Dis; 2018 May; 21(5):975-981. PubMed ID: 29878618
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid induced osteoporosis.
Hu K; Adachi JD
Expert Rev Endocrinol Metab; 2019 Jul; 14(4):259-266. PubMed ID: 31094232
[TBL] [Abstract][Full Text] [Related]
36. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
37. Prevention and treatment of glucocorticoid-induced osteoporosis.
Curtis JR; Saag KG
Curr Osteoporos Rep; 2007 Mar; 5(1):14-21. PubMed ID: 17320023
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid-induced osteoporosis.
Silverman SL; Lane NE
Curr Osteoporos Rep; 2009 Mar; 7(1):23-6. PubMed ID: 19239826
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid-induced osteoporosis: 2019 concise clinical review.
Adami G; Saag KG
Osteoporos Int; 2019 Jun; 30(6):1145-1156. PubMed ID: 30805679
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, determinants, and inappropriateness of calcium supplementation among men and women in a Spanish Mediterranean area: cross-sectional data from the ESOSVAL cohort.
Sanfélix-Gimeno G; Sanfélix-Genovés J; Rodriguez-Bernal CL; Peiró S; Hurtado I
J Bone Miner Res; 2013 Nov; 28(11):2286-94. PubMed ID: 23661631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
